Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits

BACKGROUND: Antipsychotic-induced weight gain constitutes a major unresolved clinical problem which may ultimately be associated with reducing life expectancy by 25 years. Overweight is associated with brain deterioration, cognitive decline and poor quality of life, factors which are already comprom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebdrup, Bjørn H, Knop, Filip K, Ishøy, Pelle L, Rostrup, Egill, Fagerlund, Birgitte, Lublin, Henrik, Glenthøj, Birte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573939/
https://www.ncbi.nlm.nih.gov/pubmed/22891821
http://dx.doi.org/10.1186/1741-7015-10-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573939/
https://www.ncbi.nlm.nih.gov/pubmed/22891821
http://dx.doi.org/10.1186/1741-7015-10-92

Ejemplares similares